IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0925235
(2004-08-24)
|
등록번호 |
US-7325689
(2008-02-05)
|
발명자
/ 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
23 인용 특허 :
75 |
초록
▼
A pharmaceutical package assembly includes a tether having a fold-over card mating feature, and a fold-over card configured to house one or more pharmaceutical blisters, wherein the fold-over card includes a tether mating feature. One exemplary method of coupling the fold-over card to a tether inclu
A pharmaceutical package assembly includes a tether having a fold-over card mating feature, and a fold-over card configured to house one or more pharmaceutical blisters, wherein the fold-over card includes a tether mating feature. One exemplary method of coupling the fold-over card to a tether includes forming a tether receiving recess in the front side of the fold-over card, folding the front side of the fold-over card adjacent to the back side of the fold-over card so that the tether receiving recess reveals an exposed portion of the fold-over card front side, and coupling the tether to the revealed portion of the card front side. Another exemplary method of coupling a fold-over card to a tether having a front side and a back side includes forming a fold-over card receiving recess in the tether such that when the front side of the tether is folded adjacent to the back side of the tether, the fold-over card receiving recess reveals an exposed portion of the tether, and coupling the fold-over card to the revealed portion of the tether.
대표청구항
▼
What is claimed is: 1. A pharmaceutical package assembly comprising: a tether comprising: a fold-over card mating member; and a housing mating member configured to be coupled to a package housing; and a fold-over card coupled to the tether and configured to house one or more pharmaceutical blister
What is claimed is: 1. A pharmaceutical package assembly comprising: a tether comprising: a fold-over card mating member; and a housing mating member configured to be coupled to a package housing; and a fold-over card coupled to the tether and configured to house one or more pharmaceutical blisters, said fold-over card comprising: a front member having a tether mating portion; a back member being separated from the front member by a crease; and a tether receiving recess formed on said back member such that when said fold-over card is folded along said crease, said tether mating portion of said front member remains exposed. 2. The pharmaceutical package of claim 1, wherein said front member is configured to be foldably coupled to said back member. 3. The pharmaceutical package of claim 2, farther comprising: at least one pharmaceutical access orifice formed in the front member; and at least one pharmaceutical access orifice formed in the back member; wherein said pharmaceutical access orifice formed in the front member is configured to be concentrically aligned with said pharmaceutical access orifice formed in the back member when said fold-over card is folded along said crease. 4. The pharmaceutical package of claim 1, wherein said tether mating portion of said front member is coupled to said fold-over card mating member by an adhesive. 5. The pharmaceutical package of claim 4, wherein said adhesive comprises a heat seal adhesive. 6. The pharmaceutical package of claim 1, wherein said fold-over card mating member and said tether receiving recess comprise mating equivalents. 7. The pharmaceutical package of claim 1, further comprising at least one pharmaceutical access orifice formed in said fold-over card. 8. The pharmaceutical package of claim 7, wherein said pharmaceutical package secures at least one pharmaceutical blister in said at least one pharmaceutical access orifice formed in said card front. 9. A pharmaceutical package assembly comprising: a tether including a fold-over card mating member; a fold-over card configured to house one or more pharmaceutical blisters; said fold-over card including a front member having a tether mating portion, a back member including a tether receiving recess, and a crease separating said front member and said back member; and said tether receiving recess being formed on said back member such that when said fold-over card is folded along said crease, said tether mating portion of said front member remains exposed. 10. The pharmaceutical package of claim 9, wherein said front member is configured to be foldably coupled to said back member. 11. The pharmaceutical package of claim 10, further comprising: at least one pharmaceutical access orifice formed in the front member; and at least one pharmaceutical access orifice formed in the back member; wherein said pharmaceutical access orifice formed in the front member is configured to be concentrically aligned with said pharmaceutical access orifice formed in the back member when said fold-over card is folded along said crease. 12. The pharmaceutical package of claim 11, wherein said pharmaceutical package is configured to secure at least one pharmaceutical blister in said at least one pharmaceutical access orifice formed in said card front. 13. The pharmaceutical package of claim 9, wherein said tether mating portion of said front member is coupled to said card mating member by an adhesive. 14. The pharmaceutical package of claim 13, wherein said adhesive comprises a heat seal adhesive. 15. The pharmaceutical package of claim 9, wherein said fold-over card mating member and said tether receiving recess comprise mating equivalents. 16. A pharmaceutical package assembly comprising: a tether including a fold-over card mating member; a fold-over card configured to house one or more pharmaceutical blisters; said fold-over card including a front member having a tether mating portion corresponding to said fold-over card mating member and a pharmaceutical access orifice configured to secure at least one pharmaceutical blister, a back member including a tether receiving recess, and a crease separating said front member and said back member, said front member being configured to be foldably coupled to said back member; and said tether receiving recess being formed on said back member such that when said fold-over card is folded along said crease, said tether mating portion of said front member remains exposed, said tether mating portion of said front member being configured to be coupled to said card mating member by an adhesive. 17. The pharmaceutical package of claim 16, further comprising: at least one pharmaceutical access orifice formed in the back member; wherein said pharmaceutical access orifice formed in the front member is concentrically aligned with said pharmaceutical access orifice formed in the back member when said fold-over card is folded along said crease. 18. The pharmaceutical package of claim 17, wherein said adhesive comprises a heat seal adhesive. 19. A pharmaceutical package comprising: a tether coupled to a package housing, wherein said tether includes a fold-over card mating member; and a fold-over card configured to house one or more blister cards, said fold-over card including a front section, a back section and a tether mating member, the tether mating member comprising a receiving recess configured such that when said fold-over card is folded, overlapping said front section and said back section, a tether adhering portion of said fold-over card remains exposed, said tether adhering portion being coupled to said card mating member by an adhesive. 20. The pharmaceutical package of claim 19, wherein said adhesive comprises a heat seal adhesive. 21. A blister package assembly comprising: a tether including a fold-over card mating member; a fold-over card configured to house one or more blister package blisters; said fold-over card including a tether mating member and comprising: a front member having a tether mating portion; a back member including a tether receiving recess; and a crease separating said front member and said back member, said tether receiving recess being formed on said back member such that when said fold-over card is folded along said crease, said tether mating portion of said front member remains exposed. 22. The blister package assembly of claim 21, wherein said front member is configured to be foldably coupled to said back member. 23. The blister package assembly of claim 21, further comprising: at least one blister package access orifice formed in the front member; and at least one blister package access orifice formed in the back member; wherein said blister package access orifice formed in the front member is concentrically aligned with said blister package access orifice formed in the back member when said fold-over card is folded along said crease. 24. The blister package assembly of claim 21, wherein said tether mating portion of said fold-over card is coupled to said card mating member by a heat seal adhesive. 25. The pharmaceutical package of claim 9, wherein the tether mating portion of the front member of the fold-over card is coupled to the fold-over card mating member of the tether. 26. The pharmaceutical package assembly of claim 16, wherein the tether mating portion of the front member of the fold-over card is coupled to the card mating member of the tether by the adhesive. 27. A pharmaceutical package assembly comprising: a tether comprising: a front portion; and a back portion separated from the front portion by a first crease, a recess being formed on the front portion such that when the tether is folded along the first crease, a portion of the back portion remains exposed; and a fold-over card configured to house one or more pharmaceutical blisters, the fold-over card comprising: a front member; a back member separated from the front member by a second crease; and a tether mating member coupled to the back member, the tether mating member being configured to be received within the recess formed on the front portion of the tether. 28. The pharmaceutical package assembly of claim 27, wherein the tether mating member is attached to the portion of the back portion that is exposed. 29. The pharmaceutical package assembly of claim 27, wherein the front portion of the tether is foldably coupled to the back portion of the tether. 30. The pharmaceutical package assembly of claim 27, wherein the front member of the fold-over card is foldably coupled to the back member of the fold-over card. 31. The pharmaceutical package of claim 27, further comprising: a first pharmaceutical access orifice formed in the front member; and a second pharmaceutical access orifice formed in the back member; wherein the first pharmaceutical access orifice is concentrically aligned with the second pharmaceutical access orifice when the fold-over card is folded along the first crease. 32. The pharmaceutical package of claim 31, wherein the pharmaceutical package secures a pharmaceutical blister in the first pharmaceutical access orifice. 33. The pharmaceutical package assembly of claim 1, further comprising: a package housing, wherein the housing mating member of the tether is coupled to the package housing. 34. The pharmaceutical package assembly of claim 33, wherein the package housing bounds a compartment such that the tether and the fold-over card can selectively slide into and out of the compartment when the housing mating member is coupled to the package housing.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.